Absci (ABSI) Minority Interest (2020 - 2021)
Absci (ABSI) posted Minority Interest of $161.4 million for Q2 2021, up 3.16% sequentially from $156.4 million in Q4 2020.
Powered by 
Analysis
Absci (ABSI) Minority Interest (2020 - 2021) Analysis & Trends
Absci has reported Minority Interest for 2 years, with the latest figure at $161.4 million in Q2 2021.
- Quarterly Minority Interest changed N/A year-over-year to $161.4 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $161.4 million (changed N/A YoY) and the FY2020 annual result came in at $156.4 million, changed N/A from the prior year.
- Minority Interest grew to $161.4 million in Q2 2021 per ABSI's latest filing, from $156.4 million in the prior quarter.
- Over five years, Minority Interest peaked at $161.4 million in Q2 2021 and troughed at $156.4 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - |